{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:54:34Z","timestamp":1777089274769,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aims of this study were to determine the prevalence of the different anti-erythrocytic alloantibodies, to describe pregnancy outcomes according to a low-risk and high-risk classification for fetal anemia and to determine the factors that influence adverse perinatal outcomes.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective observational study included women referred to our center following the identification of maternal anti-erythrocytic alloantibodies between 2002 and 2017. Pregnancies were classified as high risk for fetal anemia in cases with clinically significant antibodies, no fetal-maternal compatibility and titers \u22651:16 or any titration in cases of Kell system incompatibility. In high-risk pregnancies, maternal antibody titration and the fetal middle cerebral artery peak systolic velocity (MCA-PSV) were monitored. Low-risk pregnancies underwent routine pregnancy follow-up.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Maternal antibodies were found in 337 pregnancies, and 259 (76.9%) of these antibodies were clinically significant. The most frequent antibodies were anti-D (53%) and anti-K (19%). One hundred forty-three pregnancies were classified as low risk for fetal anemia, 65 (25%) cases were classified as no fetal-maternal incompatibility, 78 had clinically nonsignificant antibodies, 4 (2.8%) resulted in first-trimester pregnancy loss, and 139 (97.2%) resulted in livebirths. Of the 194 high-risk pregnancies, 38 had titers &lt;\u20091:16 (resulting in 38 livebirths), and 156 had titers \u22651:16 or anti-K antibodies. In the last group, 6 cases miscarried before 18\u2009weeks, 93 had a MCA-PSV &lt;\u20091.5 multiples of the median (MoM), resulting in 3 perinatal deaths that were unrelated to fetal anemia, one termination and 89 livebirths; and 57 had a MCA-PSV &gt;\u20091.5 MoM, resulting in 3 intrauterine deaths, 6 terminations and 48 livebirths. Ninety-two intrauterine transfusions were performed in 45 fetuses (87% anti-D). Adverse outcomes were related to a MCA-PSV\u2009&gt;\u20091.5 MoM (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), hydrops (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and early gestational age at first transfusion (<jats:italic>p<\/jats:italic>\u2009=\u20090.029)<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Anti-D remains the most common antibody in fetuses requiring intrauterine transfusion. A low or high-risk classification for fetal anemia based on the type of antibody, paternal phenotype and fetal antigen allows follow-up of the pregnancy accordingly, with good perinatal outcomes in the low-risk group. In the high-risk group, adverse perinatal outcomes are related to high MCA-PSV, hydrops and early gestational age at first transfusion.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-019-2525-y","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T12:47:42Z","timestamp":1571143662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital"],"prefix":"10.1186","volume":"19","author":[{"given":"Mar\u00eda \u00c1ngeles","family":"S\u00e1nchez-Dur\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Higueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Halajdian-Madrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayte","family":"Avil\u00e9s Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bernabeu-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8261-6383","authenticated-orcid":false,"given":"Nerea","family":"Maiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Nogu\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"key":"2525_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/9780470986868.ch12","volume-title":"Mollison\u2019s blood transfusion in clinical medicine","author":"HG Klein","year":"2005","unstructured":"Klein HG, Anstee DJ. Haemolytic disease of the fetus and the newborn. In: Mollison\u2019s blood transfusion in clinical medicine. 11th ed. Oxford: Blackwell Science; 2005. p. 496\u2013545.","edition":"11"},{"key":"2525_CR2","doi-asserted-by":"publisher","unstructured":"Daniels G. Blood group antibodies in haemolytic disease of the fetus and newborn. In: Alloimmune Disorders of Pregnancy: Anaemia, Thrombocytopenia and Neutropenia in the Fetus and Newborn. Cambridge: Cambridge University Press; 2002. p. 21\u201340. \n                    https:\/\/doi.org\/10.1017\/CBO9780511527043.004\n                    \n                  .","DOI":"10.1017\/CBO9780511527043.004"},{"key":"2525_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1537-2995.2007.01625.x","volume":"48","author":"JM Koelewijn","year":"2008","unstructured":"Koelewijn JM, Vrijkotte TGM, Schoot CEVD, Bonsel GJ, Haas MD. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008;48:941\u201352.","journal-title":"Transfusion"},{"key":"2525_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1469-0705.1995.05060400.x","volume":"5","author":"G Mari","year":"1995","unstructured":"Mari G, Adrignolo A, Abuhamad AZ, Pirhonen J, Jones DC, Ludomirsky A, et al. Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization. Ultrasound Obstet Gynecol. 1995;5:400\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2525_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.7863\/jum.2005.24.5.697","volume":"24","author":"G Mari","year":"2005","unstructured":"Mari G. Middle cerebral artery peak systolic velocity. J Ultrasound Med. 2005;24:697\u2013702.","journal-title":"J Ultrasound Med"},{"key":"2525_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1056\/NEJMoa052855","volume":"355","author":"D Oepkes","year":"2006","unstructured":"Oepkes D, Seaward PG, Vandenbussche FPHA, Windrim R, Kingdom J, Beyene J, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med. 2006;355:156\u201364.","journal-title":"N Engl J Med"},{"key":"2525_CR7","first-page":"589","volume":"99","author":"G Mari","year":"2002","unstructured":"Mari G, Detti L, Oz U, Zimmerman R, Duerig P, Stefos T. Accurate prediction of fetal hemoglobin by Doppler ultrasonography. Obstet Gynecol. 2002;99:589\u201393.","journal-title":"Obstet Gynecol"},{"key":"2525_CR8","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","volume":"120","author":"KJ Moise","year":"2012","unstructured":"Moise KJ, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol. 2012;120:1132\u20139.","journal-title":"Obstet Gynecol"},{"key":"2525_CR9","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood.V83.4.1156.1156","volume":"83","author":"R Warwick","year":"1994","unstructured":"Warwick R, Bennett P. RhD genotyping of the fetus using amniotic fluid. Blood. 1994;83:1156\u20137.","journal-title":"Blood"},{"key":"2525_CR10","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJM199812103392402","volume":"339","author":"YMD Lo","year":"1998","unstructured":"Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med. 1998;339:1734\u20138.","journal-title":"N Engl J Med"},{"key":"2525_CR11","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1111\/j.1537-2995.2007.01437.x","volume":"47","author":"K Finning","year":"2007","unstructured":"Finning K, Martin P, Summers J, Daniels G. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion. 2007;47:2126\u201333.","journal-title":"Transfusion"},{"key":"2525_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/pd.1936","volume":"28","author":"Y Li","year":"2008","unstructured":"Li Y, Finning K, Daniels G, Hahn S, Zhong X, Holzgreve W. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenat Diagn. 2008;28:203\u20138.","journal-title":"Prenat Diagn"},{"key":"2525_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejogrb.2019.04.016","volume":"237","author":"I Awowole","year":"2019","unstructured":"Awowole I, Cohen K, Rock J, Sparey C. Prevalence and obstetric outcome of women with red cell antibodies in pregnancy at the Leeds teaching hospitals NHS trust, West Yorkshire, England. Eur J Obstet Gynecol Reprod Biol. 2019;237:89\u201392.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2525_CR14","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1111\/trf.14262","volume":"57","author":"G Bollason","year":"2017","unstructured":"Bollason G, Hjartardottir H, Jonsson T, Gudmundsson S, Kjartansson S, Halldorsdottir AM. Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study: alloimmunization in pregnancy in iceland. Transfusion. 2017;57:2578\u201385.","journal-title":"Transfusion"},{"key":"2525_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/aogs.12590","volume":"94","author":"S Sainio","year":"2015","unstructured":"Sainio S, Nupponen I, Kuosmanen M, Aitokallio-Tallberg A, Ekholm E, Halmesm\u00e4ki E, et al. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study. Acta Obstet Gynecol Scand. 2015;94:383\u201390.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2525_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/pd.5355","volume":"38","author":"C Zwiers","year":"2018","unstructured":"Zwiers C, Oepkes D, Lopriore E, Klumper FJ, de Haas M, van Kamp IL. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization. Prenat Diagn. 2018;38:943\u201350.","journal-title":"Prenat Diagn"},{"key":"2525_CR17","first-page":"129","volume":"7","author":"SA Pasman","year":"2015","unstructured":"Pasman SA, Claes L, Lewi L, Schoubroeck DV, Debeer A, Emonds M, et al. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven. Facts Views Vis Obgyn. 2015;7:129\u201336.","journal-title":"Facts Views Vis Obgyn"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2525-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-019-2525-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2525-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T23:08:18Z","timestamp":1602630498000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-019-2525-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2525"],"URL":"https:\/\/doi.org\/10.1186\/s12884-019-2525-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was provided by the Ethical Committee CEIC Vall d\u2019Hebron Research Institute, PR (AMI) 467\/2018. The ethics committee has authorized the waiving of consent by the patients as this is a retrospective study. No procedures other than those established in the usual protocol were performed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}